Quotient Limited to Expand Capability of Its MosaiQ™ Next-Generation Transfusion Diagnostics Platform to Include Nucleic Acid Testing Initial feasibility study demonstrates ability to detect nucleic acid using MosaiQTMPotential for a single unified platform to perform blood grouping along with serological and molecular disease...